Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide

BACKGROUND: We previously identified three short single peptides (P4, P6 and P7) representing different B-cell epitopes on the extracellular domain of Her-2/neu for a vaccine that was tested in a phase-I clinical trial. Here we describe the improvement of the multi peptide vaccine by fusing the sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobias, Joshua, Jasinska, Joanna, Baier, Karin, Kundi, Michael, Ede, Nicholas, Zielinski, Christoph, Wiedermann, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301331/
https://www.ncbi.nlm.nih.gov/pubmed/28183282
http://dx.doi.org/10.1186/s12885-017-3098-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301331/
https://www.ncbi.nlm.nih.gov/pubmed/28183282
http://dx.doi.org/10.1186/s12885-017-3098-7

Ejemplares similares